11 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18590860 | SYSTEMS AND METHODS FOR COORDINATING MANUFACTURING OF CELLS FOR PATIENT-SPECIFIC IMMUNOTHERAPY | HUYNH, EMILY | 3683 | Final Rejection | Feb 28, 2024 |
| 18262843 | ADJUVANT THERAPY FOR CANCER | WEN, SHARON X | 1641 | Non-Final OA | Jul 25, 2023 |
| 18256853 | TREATMENT OF CANCERS WITH TUMOR INFILTRATING LYMPHOCYTE THERAPIES | CUNNINGCHEN, KATHLEEN MARY | 1646 | Non-Final OA | Jun 09, 2023 |
| 18247878 | TREATMENT OF NSCLC PATIENTS WITH TUMOR INFILTRATING LYMPHOCYTE THERAPIES | AEDER, SEAN E | 1642 | Non-Final OA | Apr 04, 2023 |
| 17997731 | PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF THE SAME IN IMMUNOTHERAPY | ZHU, JIANJIAN | 1631 | Non-Final OA | Nov 01, 2022 |
| 17997648 | SELECTION OF IMPROVED TUMOR REACTIVE T-CELLS | RAHMAN, MASUDUR | 1633 | Final Rejection | Oct 31, 2022 |
| 17829087 | RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES | KELLY, ROBERT M | 1638 | Final Rejection | May 31, 2022 |
| 17771723 | GENE EDITING OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY | BERTOGLIO, VALARIE E | 1632 | Final Rejection | Apr 25, 2022 |
| 17267699 | Expansion of TILs from Cryopreserved Tumor Samples | O'NEILL, MARISOL ANN | 1633 | Final Rejection | Jan 10, 2022 |
| 17440639 | SEQUENTIAL HETEROLOGOUS BOOST ONCOLYTIC VIRAL IMMUNOTHERAPY | GILL, RACHEL B | 1671 | Non-Final OA | Sep 17, 2021 |
| 17415175 | Methods of Expanding Tumor Infiltrating Lymphocytes Using Engineered Cytokine Receptor Pairs and Uses Thereof | KOLKER, DANIEL E | 1645 | Non-Final OA | Jun 17, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial